Literature DB >> 1845887

Expression of bovine herpesvirus 1 glycoprotein gIV by recombinant baculovirus and analysis of its immunogenic properties.

S van Drunen Littel-van den Hurk1, M D Parker, D R Fitzpatrick, T J Zamb, J V van den Hurk, M Campos, R Harland, L A Babiuk.   

Abstract

The gene encoding the gIV glycoprotein of bovine herpesvirus 1 has been inserted into the genome of Autographa californica baculovirus in lieu of the coding region of the A. californica baculovirus polyhedrin gene. Recombinant protein was identified by its reactivity with gIV-specific monoclonal antibodies and expressed at high levels (about 85 micrograms per 2.5 x 10(6) cells) in Spodoptera frugiperda (SF9) cells. The recombinant glycoprotein had an apparent molecular mass of 63 kDa, indicating that it was incompletely glycosylated. However, it was transported to and expressed on the cell surface of infected SF9 cells. Furthermore, reactivity with polyclonal and monoclonal antibodies specific for gIV suggested that most epitopes were functionally unaltered on the recombinant gIV. Immunization of cattle with recombinant gIV in crude, partially purified, or pure form resulted in the induction of neutralizing antibodies to BHV-1, which were reactive with authentic gIV. However, the neutralizing antibody titers were lower than those elicited by an equivalent amount of affinity-purified authentic gIV, which appeared to be mainly due to reduced recognition of one of the neutralizing antigenic domains of gIV, designated domain I. The potential use of this recombinant gIV glycoprotein as a vaccine to bovine herpesvirus 1 infection in cattle is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845887      PMCID: PMC240513     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Immunization of cotton rats with the human respiratory syncytial virus F glycoprotein produced using a baculovirus vector.

Authors:  M W Wathen; R J Brideau; D R Thomsen
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

2.  Topographical analysis of antigenic determinants on envelope glycoprotein V3 (E) of Japanese encephalitis virus, using monoclonal antibodies.

Authors:  J Kimura-Kuroda; K Yasui
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

3.  Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins.

Authors:  S van Drunen Littel-van den Hurk; G A Gifford; L A Babiuk
Journal:  Vaccine       Date:  1990-08       Impact factor: 3.641

4.  Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells.

Authors:  S K Tikoo; D R Fitzpatrick; L A Babiuk; T J Zamb
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  Lymphocyte proliferative responses to separated bovine herpesvirus 1 proteins in immune cattle.

Authors:  D L Hutchings; S van Drunen Littel-van den Hurk; L A Babiuk
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

6.  Modification and secretion of human interleukin 2 produced in insect cells by a baculovirus expression vector.

Authors:  G E Smith; G Ju; B L Ericson; J Moschera; H W Lahm; R Chizzonite; M D Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells.

Authors:  M J Lawman; R J Courtney; R Eberle; P A Schaffer; M K O'Hara; B T Rouse
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

8.  High level expression of nonfused foreign genes with Autographa californica nuclear polyhedrosis virus expression vectors.

Authors:  V A Luckow; M D Summers
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

9.  Production of human beta interferon in insect cells infected with a baculovirus expression vector.

Authors:  G E Smith; M D Summers; M J Fraser
Journal:  Mol Cell Biol       Date:  1983-12       Impact factor: 4.272

10.  The effect of dose, route and virulence of bovine herpesvirus 1 vaccine on experimental respiratory disease in cattle.

Authors:  K W Jericho; L A Babiuk
Journal:  Can J Comp Med       Date:  1983-04
View more
  8 in total

Review 1.  Uses of flow cytometry in virology.

Authors:  J J McSharry
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

2.  Processing and antigenicity of entire and anchor-free spike glycoprotein S of coronavirus TGEV expressed by recombinant baculovirus.

Authors:  M Godet; D Rasschaert; H Laude
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

Review 3.  BHV-1: new molecular approaches to control a common and widespread infection.

Authors:  L Turin; S Russo; G Poli
Journal:  Mol Med       Date:  1999-05       Impact factor: 6.354

4.  Role of N-linked glycans in antigenicity, processing, and cell surface expression of bovine herpesvirus 1 glycoprotein gIV.

Authors:  S K Tikoo; M D Parker; J V van den Hurk; J Kowalski; T J Zamb; L A Babiuk
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

5.  Glycoprotein IV of bovine herpesvirus 1-expressing cell line complements and rescues a conditionally lethal viral mutant.

Authors:  F Fehler; J M Herrmann; A Saalmüller; T C Mettenleiter; G M Keil
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

6.  Characterization of membrane-bound and membrane anchor-less forms of hemagglutinin glycoprotein of Rinderpest virus expressed by baculovirus recombinants.

Authors:  S Naik; M S Shaila
Journal:  Virus Genes       Date:  1997       Impact factor: 2.198

Review 7.  Vaccines for viral and parasitic diseases produced with baculovirus vectors.

Authors:  Monique M van Oers
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

8.  Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice.

Authors:  Qiliang Liu; Kang Liu; Chunyi Xue; Jianqiang Zhou; Xiaoming Li; Dongyu Luo; Jing Zheng; Shun Xu; George Dacai Liu; Yongchang Cao
Journal:  Vaccine       Date:  2014-04-03       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.